The human papillomavirus (HPV) vaccine, Gardasil, does not increase the incidence of flares (unpredictable worsening of symptoms signaling increased disease activity) in patients with systemic lupus erythematosus (SLE), or lupus, and has a tolerable safety profile, according to new research.